We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
European Union antitrust regulators on Wednesday approved General Electric Co.'s 5.99 billion euros ($8.3 billion) bid to buy the diagnostics business of Abbott Laboratories. Read More
The Wyeth Corporation is to establish a new R&D laboratory at its Grange Castle campus in Dublin, Minister for Enterprise, Trade and Employment Micheál Martin announced. Read More
To mark Africa Malaria Day earlier this week, Novartis announced it delivered 4.7 million courses of its life-saving malaria drug, Coartem, to Tanzania, where malaria is the leading cause of death in both children and adults. Read More
Sanofi Pasteur MSD has submitted data to the European Medicines Agency (EMEA) in an effort to add to the indications for its cervical cancer vaccine, Gardasil. Read More
Roche's pending applications for investigational erythropoiesis-stimulating agent (ESA) Mircera in the U.S. and Europe are proceeding according to plan, William Burns, CEO of Roche's pharma division, said. Read More
The UK Department of Health (DoH) is urging all medicines and medical technology manufacturers to use the GS1 autoidentification and data capturing (AIDC) system for tracking products supplied to the English National Health System (NHS).
Language in newly signed free trade agreements (FTAs) covering data exclusivity and patent extension could delay generic drug entry in foreign markets where access to low-cost medicines is highly needed, a bipartisan group of lawmakers contends.
Trade representatives from the U.S. and South Korea April 1 successfully concluded months-long negotiations on a fair trade agreement (FTA) that includes provisions to increase access to innovative medicines and medical technologies and lengthen patent exclusivity for original products.
Australia’s Department of Health and Ageing (DHA) has posted a draft version of legislation establishing the joint Australia New Zealand Therapeutic Products Authority (ANZTPA).